Real-time Euronext Paris 11:23:25 2024-04-19 am EDT 5-day change 1st Jan Change
86.63 EUR +1.64% Intraday chart for Sanofi +0.20% -3.48%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global markets live: P&G, Amex, Blackstone, Apple, Tesla... Our Logo
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Sector Update: Health Care MT
Sanofi Planning to Restructure US Commercial Operations for Vaccines; Job Losses Likely MT
Sanofi Reportedly Planning to Restructure US Commercial Operations for Vaccines; Job Losses Likely MT
Sanofi to overhaul US operations of vaccines, cut jobs RE
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading MT
SANOFI : JP Morgan reiterates its Neutral rating ZD
Sanofi Announces Quebec's INESSS Recommends BEYFORTUS® for Prevention of RSV for All Infants 8 Months of Age and Younger CI
IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets MT
BeiGene to Award Shares Worth $15 Million to 11 Directors MT
Sanofi's Frexalimab Reduces Disease Activity in Multiple Sclerosis Patients in Phase 2 Trial MT
Sanofi: new positive phase II results in MS CF
IDT Australia Signs Master Service Agreement with Sanofi MT
Sanofi: progress in hematology trial CF
Innate Pharma: progress in hematology trial CF
Weight-Loss Drugs Like Wegovy Don't Cause Suicidal Thoughts, EU Says DJ
European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs MT
EU regulator finds no link between weight-loss drugs and suicidal thoughts RE
Nurix Therapeutics Shares Climb 19% on Extended Sanofi Collaboration DJ
Nurix Therapeutics Extends Collaboration With Sanofi, Aims to Nominate Clinical Candidate MT
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6 CI
Sanofi Launches Rabies Vaccine in the UK MT
Sanofi: rabies vaccine launched in the UK CF
Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups CI
Chart Sanofi
More charts
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
85.23 EUR
Average target price
107.5 EUR
Spread / Average Target
  1. Stock Market
  2. Equities
  3. SAN Stock
  4. News Sanofi
  5. Sanofi Gets Early Interest from EQT, Others for $20 Billion Consumer Health Division